Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


CDC Resources: Infection

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Centers for Disease Control and Prevention (CDC). These resources are categorized as Infection.  ‚Äč

The information provided is for educational purposes for SCCM members and the general public. Clicking on these links allows users to leave www.sccm.org. The Society does not control the linked sites or the content on those sites. SCCM does not assume any liability for the content or information contained on these linked sites. Further, SCCM does not assume any liability or warrant with respect to the quality, noninfringement, accuracy, completeness, timeliness, or reliability of such linked sites.You should be aware that other internet sites that link to the Site may contain privacy provisions that differ from these policies. To ensure that your privacy is protected, we recommend that you review the privacy policies of other internet sites you visit.
 

Scientific Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2
Information regarding the community use of cloth masks to control the spread of SARS-CoV-2.

Toolkit for Healthcare Providers
Guidance and tools to help clinicians make decisions, protect patients and employees, and communicate with their communities.

Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic
This guidance has been updated based on currently available information about COVID-19 and the current situation in the United States. 

SARS-CoV-2 Reinfection Criteria
The CDC has released new web content that outlines criteria on COVID-19 cases that should be assessed for suspected reinfection with SARS-CoV-2. The criteria outlines standards that laboratory tests should meet when evaluating specimens for reinfection. CDC also issued a protocol intended to provide state and local health departments with a standardized framework and toolkit for investigating suspected cases of SARS-CoV-2 reinfection.

Strategies for Optimizing the Supply of Facemasks
Information regarding strategies for optimizing the supply of facemasks.

Late Sequelae of COVID-19
Information on late sequelae of COVID-19. 

COVID-19 Science Updates
To help inform CDC’s COVID-19 Response, as well as to help CDC staff stay up to date on the latest COVID-19 research, the Response’s Office of the Chief Medical Officer has collaborated with the CDC Office of Library Science to create a series called COVID-19 Science Update.

COVID-19 Science Updates (Edition 70)
To help inform CDC’s COVID-19 Response, as well as to help CDC staff stay up to date on the latest COVID-19 research, the Response’s Office of the Chief Medical Officer has collaborated with the CDC Office of Library Science to create a series called COVID-19 Science Update.

COVID-19 Webinar & Partner Calls Videos
This is a link to the CDC COVID-19 external resource to COVID-19 webinars and partner calls.

New Variant Strain
This is a link to the CDC COVID-19 external resource regarding implications of the emerging SARS-CoV-2 Variant VUI 202012/01.

Summary for Healthcare Facilities: Strategies for Optimizing the Supply of PPE during Shortages
This is a link to the CDC COVID-19 external resource regarding strategies for optimizing the supply of PPE during shortages.

COVID Data Tracker 
This is a link to the CDC COVID-19 external resource where users can monitor the latest data for any county’s hospital admissions and occupied hospital and ICU beds in the COVID Data Tracker. Users can also search county data to find the latest hospital data, cases, deaths, and more.

Project Firstline Resources
This is a link to the CDC COVID-19 external resource. The Project Firstline website just expanded and it’s now easier than ever to stay up to date on the latest information from CDC’s infection control training collaborative. 

Strategies for Optimizing the Supply of N95 Respirators
This document offers a series of strategies or options to optimize supplies of disposable N95 filtering facepiece respirators (commonly called “N95 respirators”) in healthcare settings when there is limited supply. This guidance has been updated to include clarifications on use of facemasks as a crisis capacity strategy.

Emerging Variants
This link covers new variants of the virus that causes COVID-19.

Interim Guidance on Duration of Isolation and Precautions for Adults with COVID-19
This link covers interim guidance on duration of isolation and precautions for adults with COVID-19.

Updated Discontinuation of Transmission-Based Precautions and Disposition of Patients with SARS-CoV-2 Infection in Healthcare Settings 
This is a link to the CDC external resources regarding patients who are severely immunocompromised could remain infectious more than 20 days after symptom onset.  Consultation with infectious diseases specialists is recommended; use of a test-based strategy for determining when to discontinue Transmission-Based Precautions could be considered.

Options to Reduce Quarantine for Contacts of Persons with SARS-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing
This is a link to the CDC external resources regarding the options to reduce quarantine for contacts of persons with SARS-CoV-2 infection using symptom monitoring and diagnostic testings. 

Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination
This is a link to the CDC external resources regarding updated healthcare infection prevention and control recommendations in response to COVID-19 vaccination.

CDC COVID-19 Resource: Scientific Brief: SARS-CoV-2 Transmission
This scientific brief has been updated to reflect that although how we understand transmission occurs has shifted, the ways to prevent infection with this virus have not.  Modes of SARS-CoV-2 transmission are categorized here as inhalation of virus, deposition of virus on exposed mucous membranes, and touching mucous membranes with soiled hands contaminated with virus. All prevention measures that CDC recommends remain effective for these forms of transmission. 

CDC COVID-19 Resource: COVID-19 Science Update released: April 23, 2021 Edition 86
To help inform CDC’s COVID-19 Response, as well as to help CDC staff stay up to date on the latest COVID-19 research, the Response’s Office of the Chief Medical Officer has collaborated with the CDC Office of Library Science to create a series called COVID-19 Science Update.

CDC COVID-19 Resource: Post-COVID Conditions: Information for Healthcare Providers
Some patients who have been infected with SARS-COV-2 have new, recurring, or ongoing symptoms and clinical findings more than four weeks after infection, sometimes after initial symptom recovery. Post-COVID conditions can occur in patients who had varying degrees of illness during acute infection, including those who had mild or asymptomatic infections.  Medical and research communities are still learning about these post-acute symptoms and clinical findings.

Clinical Considerations: Making Masks for the Workplace: Interim Guidance from NIOSH on New Masks Which Build Upon the ASTM
NIOSH recommends a new standard in masks, called Workplace Performance and Workplace Performance Plus masks, for workplaces. Manufacturing masks that comply with the new NIOSH criteria can help protect people in the workplace from SARS-CoV-2, the virus that causes COVID-19. These masks cannot be used as a replacement for respiratory protection when it is needed.
 
Clinical Considerations: NIOSH-approved Respirators
The supply and availability of NIOSH-approved respirators have increased  significantly over the last several months. Healthcare facilities should not be using crisis capacity strategies at this time and should promptly resume conventional practices. Check the NIOSH Certified Equipment List to identify all NIOSH-approved respirators.
 
Science Brief: COVID-19 Vaccines and Vaccination
In this scientific brief, we summarize evidence available through May 19, 2021, for the currently authorized COVID-19 vaccines (administered according to the recommended schedules) and additional considerations used to inform public health recommendations for fully vaccinated people, including:

  • Vaccine efficacy and effectiveness against SARS-CoV-2 infection
  • Vaccine performance against emerging SARS-CoV-2 variant viruses
  • Impact of other prevention measures in the context of vaccination

 
COCA Call: Underlying Medical Conditions and Severe COVID-19: Evidence-based Information for Healthcare Providers
During this COCA Call, presenters updated clinicians on the underlying medical conditions associated with severe COVID-19, described the methods used to rate the evidence linking conditions to severe COVID-19, reviewed the evidence on risk for conditions included, and provided resources for healthcare providers caring for patients with underlying medical conditions.
 
COCA Call: Underlying CDC Working Group’s Technical Report on Myocarditis
The VaST session on May 17, 2021, included several presentations on myocarditis following mRNA vaccines, from the Department of Defense (DoD), the Vaccine Adverse Event Reporting System (VAERS), and Vaccine Safety Datalink (VSD). There were also brief updates from the Veteran’s Administration (VA) and the Clinical Immunization Safety Assessment (CISA) groups about their plans for future investigation of myocarditis.


Estimated Time:

Categories: Disaster, Infection,
Content Type: External Resource,